Lixte Biotechnology Inc. (LIXT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lixte Biotechnology Inc.

    NASDAQ: LIXT · Real-Time Price · USD
    4.96
    0.16 (3.33%)
    At close: Sep 10, 2025, 3:59 PM
    5.25
    5.85%
    After-hours: Sep 10, 2025, 04:56 PM EDT

    Lixte Biotechnology Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.27 -0.88 -1.28 -2.38
    PEG Ratio
    		 0.03 0.03 0.06 -0.03
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 5.52 1.12 1.56 3.35
    P/FCF Ratio
    		 -1.44 -1.05 -1.75 -3.87
    P/OCF Ratio
    		 -1.44 -1.05 -1.75 -3.87
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a n/a n/a
    Quick Ratio
    		 3.26 13.73 14.08 16.81
    Current Ratio
    		 3.26 13.73 14.08 16.81
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -711.15 -906.45
    Return on Equity
    		 -4.34 -1.27 -1.22 -1.4
    Return on Assets
    		 -3.13 -1.18 -1.14 -1.32
    Return on Invested Capital
    		 -4.32 -1.27 -1.19 -1.36
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist